Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Express Scripts
Citi
Harvard Business School
Healthtrust
Deloitte
Federal Trade Commission
Johnson and Johnson
Merck

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022567

« Back to Dashboard
NDA 022567 describes VIIBRYD, which is a drug marketed by Forest Labs Llc and is included in one NDA. It is available from three suppliers. There are five patents protecting this drug and one Paragraph IV challenge. Additional details are available on the VIIBRYD profile page.

The generic ingredient in VIIBRYD is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.

Summary for NDA: 022567

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:5
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022567

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIIBRYD
vilazodone hydrochloride
TABLET;ORAL 022567 NDA Allergan, Inc. 0456-1100 0456-1100-31 1 KIT in 1 BLISTER PACK (0456-1100-31)
VIIBRYD
vilazodone hydrochloride
TABLET;ORAL 022567 NDA Allergan, Inc. 0456-1101 0456-1101-30 1 KIT in 1 BLISTER PACK (0456-1101-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jan 21, 2011TE:RLD:Yes
Regulatory Exclusivity Expiration:Mar 16, 2018
Regulatory Exclusivity Use:CHANGE IN TARGET DOSING TO 20MG TO 40MG ORALLY ONCE DAILY
Patent:► SubscribePatent Expiration:Sep 29, 2019Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Jun 5, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Colorcon
Baxter
Deloitte
McKinsey
Fuji
Merck
Citi
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot